Alzheimer’s trial to test drug in people without symptoms
An NHS trust is taking part in an international clinical trial of an experimental Alzheimer’s drug for people who do not have memory loss. Healthy middle-aged people considered at higher risk of developing the condition will be eligible, as researchers assess whether treatment could prevent dementia symptoms from emerging.
People without memory loss will be offered an experimental Alzheimer’s drug in a clinical trial designed to examine whether the condition can be stopped before dementia symptoms emerge.
Healthy middle-aged people deemed to have a higher risk of developing Alzheimer’s will be eligible to participate. The trial is being run by an NHS trust as part of an international clinical trial aiming to prevent dementia.
THE QUESTIONS THIS EVENT LEAVES BEHIND
How will researchers determine which healthy middle-aged people are at higher risk of developing Alzheimer’s?
What evidence would show that the experimental drug prevents dementia rather than only delaying symptoms?
How will potential participants weigh the drug’s uncertain benefits against its risks when they have no memory loss?
Who will have access to the trial’s results if the treatment proves effective or ineffective?
YOUR QUESTION
Does this story leave you with another question?
Send us the question the report did not answer. It may become the next question IAQ investigates.
GLOBAL CURIOSITY MAP · AUGUST 2026